プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Kareem A.に依頼

Egypt

Ph.D. Biochemist | Cancer Diagnostics & SPSS Expert | Medical Writer with 10+ Years in Clinical Research & Biomarkers

プロフィール概要

Dr. Kareem A. Attallah, Ph.D., a U.S. citizen born in Egypt on July 27, 1990, stands as a visionary biochemist and molecular biologist revolutionizing early cancer diagnostics, particularly for hepatocellular carcinoma (HCC). Residing in New Damietta, Egypt, he has amassed over a decade of pioneering research, developing the groundbreaking HCC-Check diagnostic model that achieves exceptional sensitivity (87.9%) and specificity through multi-biomarker integration of Cytokeratin-1, Epithelial Membrane Antigen, albumin, and log AFP. His innovations, validated across CLIP and BCLC staging systems, promise to transform global oncology by enabling the detection of small tumors in high-risk populations. ​ Academic Excellence Dr. Attallah earned his Ph.D. in Pharmaceutical Sciences (Biochemistry) from Cairo University's Faculty of Pharmacy in 2024, with a thesis pioneering biochemical techniques for HCC early detection. He holds an M.Sc. in Biochemistry and Molecular Biology from the University of Sadat City's Genetic Engineering and Biotechnology Research Institute (2019), focusing on nuclear matrix proteins in colon cancer, plus dual bachelor's degrees: B.Pharm. from Ahram Canadian University (2016, honors) and B.Sc. in Zoology-Chemistry from Damietta University (2011), alongside a Postgraduate Diploma in Biochemistry (2012). Advanced training as an Egypt Clinical Scholar at Harvard Medical School (2021-2022), where he ranked in the top 5%, honed his biomarker expertise. Research Innovations A master of cutting-edge techniques like SDS-PAGE, Western blotting, electroelution, ELISA, and immunohistochemistry, Dr. Attallah excels in protein purification, cancer biomarker quantification (AFP, Glypican-3, CEA, p53), and tissue-based diagnostics for liver, colorectal, and breast cancers. He spearheaded HCC-Check's development and validation, alongside models leveraging Collagen-III and MMP-1, driving precise early detection and prognosis. His work at the Biotechnology Research Center optimizes in vitro assays for liver diseases, including fibrosis, cirrhosis, and HCC, while mentoring over 50 professionals in clinical research. ​ Prolific Publications Dr. Attallah boasts 12+ peer-reviewed publications in top journals, including Medical Oncology (2025, HCC-Check validation), Technology in Cancer Research & Treatment (2024, HCC-Check debut), Naunyn-Schmiedeberg's Archives of Pharmacology (2025, viniferin review), and Frontiers in Pharmacology (2025, morusin as drug candidate). Earlier works in the British Journal of Biomedical Science developed multi-biomarker panels for breast and colon cancers, enhancing diagnostic accuracy through NMP-52, CEA, CA19-9, and other markers. These contributions underscore his leadership in biomarker-driven oncology. ​ Professional Leadership As a research scientist (July 2024-present) and former research associate (2019-2024) at New Damietta's Biotechnology Research Center, Dr. Attallah leads R&D in diagnostic assays and disease mechanisms. He delivered keynote speeches, including at the 6th International Monothematic Conference on Viral Hepatitis (Croatia, 2019), and completed elite workshops, such as those offered by Nature Research Academies on grant writing and EBSCO database mastery. With 8+ years of mentoring undergraduates/postgraduates and 1+ year of training healthcare professionals at Egypt's Ministry of Health, he fosters next-generation scientists. ​ Global Impact Certified in digital transformation, GRE (288), ATEFL (500), and ICDL, Dr. Attallah commands bilingual fluency, GraphPad, SPSS, and MNova for rigorous analysis. His volunteer service as a medical lab analyst in university convoys and Resala Association membership amplify his commitment to community health. Dr. Attallah's trajectory positions him as a transformative force in biotech, poised for international R&D leadership in pharma and academia.

専門分野

• ★ Biochemistry
• ★ Medical Sciences
• ★ Medical Writing
• ☆ Biostatistics
• ☆ Pharmacy Education
• ☆ Clinical Pharmacy
• ☆ In vitro Diagnostics
• ☆ In vitro Diagnostic Validation
• ☆ In vitro Diagnostic Design
• ☆ Biomarker Analysis
• ☆ Clinical Laboratory Science
• ☆ Clinical Pathology
• ☆ Clinical Biochemistry
• ☆ Pharmaceutical Technology
• ☆ Continuing Medical Education (CME) Training
• ☆ Research Summaries & Abstracts
• ☆ Technical & Scientific Writing
• ☆ Journal Selection
• ☆ Manuscript & Journal Article Writing
• ☆ Experimental Protocols
• ☆ SOP & Protocol Writing
• ☆ Scientific Proofreading & Editing
• ☆ Proofreading & Editing
• ☆ Language Translation

サービス

• Writing
• Research
• Data & AI

Writing Medical Writing, General Proofreading & Editing, Translation

Research Scientific and Technical Research

Data & AI Statistical Analysis

職務経験

Researcher

Biotechnology Research Center

2月 2015 - 現在

学歴

PhD (Biochemistry)

Faculty of Pharmacy, Cairo University

3月 2021 - 7月 2024

Master of Science (Biochemistry & Molecular Biology)

University of Sadat City

2月 2015 - 5月 2019

Bachelor of Pharmacy & Pharmaceutical Science (Pharmacy)

Ahram Canadian University

9月 2011 - 7月 2016

Diploma of Biochemistry (Biochemistry)

Mansoura University Faculty of Science - Damietta Branch

10月 2011 - 9月 2012

Bachelor of Science (Zoology & Chemistry)

Mansoura University Faculty of Science - Damietta Branch

9月 2008 - 9月 2011

認定資格

• EGYPT CLINICAL SCHOLAR RESEARCH TRAINING (ECSRT)

  Harvard medical school

  6月 2020 - 現在

• INTERNATIONAL COMPUTER DRIVING LICENSE (ICDL)

  The International Computer Driving License (ICDL) Foundation

  1月 2008 - 現在

• GRE REVISED GENERAL TEST (GRE)

  Educational Testing Service (ETS)

  1月 2015 - 1月 2020

出版物

JOURNAL ARTICLE

Ahmed M. El-Dessouki, Kareem A. Attallah, Aya H. Eid, Eman S. Zaki, Samar S. Khalaf, Riham A. El-Shiekh, Nada M. Kamel, Rana M. ElBishbishy, Ahmed H. Elosaily (2026). Viniferin and its derivatives: a comprehensive review of structural variations and promising pharmacological applications in disease prevention and therapeutic development . Naunyn-Schmiedeberg's Archives of Pharmacology.

Shymaa I. A. Abdel-dayem, Sally A. Fahim, Ahmed M. El-Dessouki, Riham A. El-Shiekh, Kareem A. Attallah, Kareem Abdou, Mostafa A. Rabie (2026). Therapeutic Potentials of Girinimbine, A Carbazole Alkaloid: A Review . Revista Brasileira de Farmacognosia.

Shymaa I. A. Abdel-dayem, Sally A. Fahim, Ahmed M. El-Dessouki, Riham A. El-Shiekh, Kareem A. Attallah, Kareem Abdou, Mostafa A. Rabie(2026). Therapeutic Potentials of Girinimbine, A Carbazole Alkaloid: A Review . Revista Brasileira de Farmacognosia.

Gehad H. Mandour, Ahmed M. El-Dessouki, Kareem A. Attallah, Mahmoud A. Seliem, Ahmed R. Abdullah, Emad Gamil Khidr, Ahmed A. El-Husseiny, Riham A. El-Shiekh, Mohamed M. Hafez, Hazim O. Khalifa (2026). Exploring the therapeutic potential of naturally occurring taxifolin, a dietary flavonoid: an updated comprehensive review . Frontiers in Pharmacology.

(2026). Therapeutic Potentials of Girinimbine, A Carbazole Alkaloid: A Review . REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY.

Ahmed M El-Dessouki, Kareem A Attallah, Aya H Eid, Eman S Zaki, Samar S Khalaf, Riham A El-Shiekh, Nada M Kamel, Rana M ElBishbishy, Ahmed H Elosaily(2025). Viniferin and its derivatives: a comprehensive review of structural variations and promising pharmacological applications in disease prevention and therapeutic development . Naunyn-Schmiedeberg's archives of pharmacology.

Hany N Azzam, Ahmed M El-Dessouki, Kareem A Attallah, Mohamed A Sadek, Yara M Aboulmagd, Mennat-Allah M Hassan, Mohamed I Fahmy, Riham A El-Shiekh, Rania M Kamal, Hazim O Khalifa(2025). Morusin as a drug candidate: opportunities, limitations, and the path toward clinical translation . Frontiers in pharmacology.

Kareem A Attallah, Khaled Farid, Mohamed S Albannan(2025). Revolutionizing early HCC detection: groundbreaking validation of the HCC-check index for small tumors in Egyptian patients using CLIP and BCLC staging systems . Medical oncology (Northwood, London, England).

Kareem A. Attallah, Khaled Farid, Mohamed S. Albannan (2025). Revolutionizing early HCC detection: groundbreaking validation of the HCC-check index for small tumors in Egyptian patients using CLIP and BCLC staging systems . Medical Oncology.

Kareem A. Attallah, Ahmed M. El-Dessouki, Mai A. Abd-Elmawla, Heba R. Ghaiad, Fatma Abo-Elghiet, Aya M. Mustafa, Riham A. El-Shiekh, Heba Elosaily (2025). The therapeutic potential of naturally occurring 6-shogaol: an updated comprehensive review . Inflammopharmacology.

Kareem A Attallah, Ahmed M El-Dessouki, Mai A Abd-Elmawla, Heba R Ghaiad, Fatma Abo-Elghiet, Aya M Mustafa, Riham A El-Shiekh, Heba Elosaily(2025). The therapeutic potential of naturally occurring 6-shogaol: an updated comprehensive review . Inflammopharmacology.

(2025). Morusin as a drug candidate: opportunities, limitations, and the path toward clinical translation . FRONTIERS IN PHARMACOLOGY.

Azzam, Hany N., El-Dessouki, Ahmed M., Attallah, Kareem A., Sadek, Mohamed A., Aboulmagd, Yara M., Hassan, Mennat-Allah M., Fahmy, Mohamed I., El-Shiekh, Riham A., Kamal, Rania M., Khalifa, Hazim O. (2025). Morusin as a drug candidate: opportunities, limitations, and the path toward clinical translation . Frontiers in Pharmacology.

Attallah, K.A., El-Dessouki, A.M., Abd-Elmawla, M.A., Ghaiad, H.R., Abo-Elghiet, F., Mustafa, A.M., El-Shiekh, R.A., Elosaily, H.(2025). The therapeutic potential of naturally occurring 6-shogaol: an updated comprehensive review . Inflammopharmacology.

(2025). The therapeutic potential of naturally occurring 6-shogaol: an updated comprehensive review . INFLAMMOPHARMACOLOGY.

Attallah, Kareem A., El-Dessouki, Ahmed M., Abd-Elmawla, Mai A., Ghaiad, Heba R., Abo-Elghiet, Fatma, Mustafa, Aya M., El-Shiekh, Riham A., Elosaily, Heba (2025). The therapeutic potential of naturally occurring 6-shogaol: an updated comprehensive review . Inflammopharmacology.

Attallah, K.A., Farid, K., Albannan, M.S.(2025). Revolutionizing early HCC detection: groundbreaking validation of the HCC-check index for small tumors in Egyptian patients using CLIP and BCLC staging systems . Medical Oncology. 42. (7).

(2025). Revolutionizing early HCC detection: groundbreaking validation of the HCC-check index for small tumors in Egyptian patients using CLIP and BCLC staging systems . MEDICAL ONCOLOGY.

Attallah, Kareem A., Farid, Khaled, Albannan, Mohamed S. (2025). Revolutionizing early HCC detection: groundbreaking validation of the HCC-check index for small tumors in Egyptian patients using CLIP and BCLC staging systems . Medical Oncology.

(2025). Viniferin and its derivatives: a comprehensive review of structural variations and promising pharmacological applications in disease prevention and therapeutic development . NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY.

El-Dessouki, Ahmed M., Attallah, Kareem A., Eid, Aya H., Zaki, Eman S., Khalaf, Samar S., El-Shiekh, Riham A., Kamel, Nada M., Elbishbishy, Rana M., Elosaily, Ahmed H. (2025). Viniferin and its derivatives: a comprehensive review of structural variations and promising pharmacological applications in disease prevention and therapeutic development . Naunyn-Schmiedeberg's Archives of Pharmacology.

Kareem A Attallah, Mohamed S Albannan, Khaled Farid, Sherine M Rizk, Nevine Fathy(2024). HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study . Technology in cancer research & treatment.

Kareem A. Attallah, Mohamed S. Albannan, Khaled Farid, Sherine M. Rizk, Nevine Fathy (2024). HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study . Technology in Cancer Research & Treatment.

Attallah, K.A., Albannan, M.S., Farid, K., Rizk, S.M., Fathy, N.(2024). HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study . Technology in Cancer Research and Treatment. 23.

(2024). HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study . TECHNOLOGY IN CANCER RESEARCH & TREATMENT.

Attallah, Kareem A., Albannan, Mohamed S., Farid, Khaled, Rizk, Sherine M., Fathy, Nevine (2024). HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study . Technology in Cancer Research & Treatment.

(2020). Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinoma . British Journal of Biomedical Science.

Attallah, A.M., Albannan, M.S., El-Deen, M.S., Farid, K., Khedr, F.M., Attallah, K.A., Abdallah, S.O.(2020). Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinoma . British Journal of Biomedical Science. 77. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 58-63.

(2020). Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinoma . BRITISH JOURNAL OF BIOMEDICAL SCIENCE.

Attallah, A. M., Albannan, M. S., El-Deen, M. S., Farid, K., Khedr, F. M., Attallah, K. A., Abdallah, S. O. (2020). Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinoma . British Journal of Biomedical Science.

Abdelfattah M. Attallah, Mohamed El-Far, Mohy E. Abdel Fatah, Mohamed M. Omran, Mohamed A. Abdelrazek, Gamal. E Abdelhameed, Kareem A. Attallah, Nada A. Ahmed, Esraa A. El-Sayes, Fatma M. Khedr, et al.(2019). Combining nuclear matrix protein-52, collagen III, and matrix metalloproteinase-1 for more effective breast cancer early detection . Journal of Bioscience and Applied Research.

Abdelfattah M. Attallah, Mohamed El-Far, Mohamed M. Omran, Mohamed A. Abdelrazek, Kareem A. Attallah, Mohamed S. Elbendary, Sara A. Soliman, Rehab A. Atwa(2019). The efficiency of collagen III, metalloproteinase 1, carcinoembryonic antigen, and carbohydrate antigen 19.9 for colon cancer diagnosis . Journal of Bioscience and Applied Research.

Kareem Attallah, Abdelfattah Attallah, Mohamed El-Far, Mohamed Omran, Mohamed Abdelrazek, Mohamed Elbendary, Sara Soliman, Rehab Atwa (2019). The efficiency of collagen III, metalloproteinase 1, carcinoembryonic antigen, and carbohydrate antigen 19.9 for colon cancer diagnosis . Journal of Bioscience and Applied Research.

Kareem Attallah, Abdelfattah Attallah, Mohamed El-Far, Mohy Abdel Fatah, Mohamed Omran, Mohamed Abdelrazek, Gamal. Abdelhameed, Nada Ahmed, Esraa El-Sayes, Fatma Khedr, et al. (2019). Combining nuclear matrix protein-52, collagen III, and matrix metalloproteinase-1 for more effective breast cancer early detection . Journal of Bioscience and Applied Research.

Abdelfattah M. Attallah, Mohamed El-Far, Mohamed M. Omran, Aya M. Saeed, Mohamed S. Elbendary, Kareem A. Attallah, Khaled Mari(2018). Comparison between glypican-3 and alpha-fetoprotein in discrimination of hepatocellular carcinoma from cirrhotic patients . Journal of Bioscience and Applied Research.

(2018). Evaluation of nuclear matrix protein, fibronectin and neutrophil-to-lymphocyte ratio combined for colon cancer diagnosis increases sensitivity and specificity. BIOSCIENCE RESEARCH.

Attallah, Abdelfattah M., El-Far, Mohamed, Ebeed, Mohamed E., Abdelrazek, Mohamed A., Omran, Mohamed M., Attallah, Kareem A., Elmahdy, Elham M., Shaker, Yehia M. (2018). Evaluation of nuclear matrix protein, fibronectin and neutrophil-to-lymphocyte ratio combined for colon cancer diagnosis increases sensitivity and specificity . Bioscience Research.

(2018). Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1 . BRITISH JOURNAL OF BIOMEDICAL SCIENCE.

Attallah, A. M., El-Far, M., Ibrahim, A. R., El-desouky, M. A., Omran, M. M., Elbendary, M. S., Attallah, K. A., Qura, E. R., Abdallah, S. O. (2018). Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1 . British Journal of Biomedical Science.

Attallah, A.M., El-Far, M., Ibrahim, A.R., El-desouky, M.A., Omran, M.M., Elbendary, M.S., Attallah, K.A., Qura, E.R., Abdallah, S.O.(2018). Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1 . British Journal of Biomedical Science. 75. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 122-127.

Kareem Attallah, Abdelfattah Attallah, Mohamed El-Far, Mohamed Omran, Aya Saeed, Mohamed Elbendary, Khaled Mari (2018). Comparison between glypican-3 and alpha-fetoprotein in discrimination of hepatocellular carcinoma from cirrhotic patients . Journal of Bioscience and Applied Research.